Seems like 23andMe is two businesses: consumer and a B2B data business. The consumer side is clearly struggling because of the problems mentioned in the article (they only need one test in their life, public perception is bad because their security has had breaches). So this needs a pivot where you can change the public's perception from a one-time test to continuous health monitoring through blood markers or somethi…
> needs a pivot where you can change the public's perception from a one-time test to continuous health monitoring through blood markers or something similar, expand to tests other than genetic and make it a repeatable, accurate test that gives you more information (and obviously stop leaking people's data). "Stop leaking data"? Sounds like a step forward. > But why not focus on the B2B side? Sell access to their data…
23andMe's Fall
21–30 of 282 posts
Re: 23andMe's Fall
#22Re: 23andMe's Fall
#23I get new updated health information from 23andme perhaps 2 times per year. It's mind boggling to imagine that with all the research being done that is all that makes the cut as interesting and trsutworthy enough for 23andme to tell me about it.
In other words, a majorly failed content strategy based on fear of being shut down for providing insufficiently vetted health info.
Meanwhile, someone created multiple accounts and the ancestry results didn't match even when collected from the same person.
Re: 23andMe's Fall
#24If a healthcare startup get shout-outs from Oprah, SNL and branded Barbie dolls, is that a bad sign?
Re: 23andMe's Fall
#25Re: 23andMe's Fall
#26Re: 23andMe's Fall
#27Omg, how can a company doing genetic test burn $1.4b ? Altought better question might be, how could it be worth $6b ? :-)
Re: 23andMe's Fall
#2823andMe never had a business plan, but it didn't matter because their investors figured they had the connections to make it work (look at the explanation of how they booted out the other founder). Their Libertarian/lazy attitude towards regulation is just an example of how couldn't be bothered to even do the necessary homework. Their attitude towards their data breach is another.
Makes me wonder how good their science is. I don't know anyone on that side of their business, but comments from friends who used to work their about how their parts worked are not encouraging.
Re: 23andMe's Fall
#29Omg, how can a company doing genetic test burn $1.4b ? Altought better question might be, how could it be worth $6b ? :-)
Re: 23andMe's Fall
#30This story makes 23andme sound like a non-fraud version of Theranos, with some of the same issues around business viability, dodging the FDA, relentless PR and funding from rich friends. If a healthcare startup get shout-outs from Oprah, SNL and branded Barbie dolls, is that a bad sign?
I don’t understand how anyone ever thought 23andMe had a viable business model selling a test that only needed to be done once(and apparently selling it at a loss to boot)